Budget 22 balanced, fiscally prudent and growth oriented: US-India forum

February 02, 2022 08:58

Finance Minister Nirmala Sitharaman has been able to once again come up with an impactful and visionary budget which is balanced, fiscally prudent and growth oriented in the midst of third wave of COVID-19, the USA India Chamber of Commerce said.

"Opting to keep the fiscal deficit at 6.9 per cent and increase capital expenditure by 35 per cent is a masterstroke. The annual budget estimates the effective capital expenditure of Rs 10.68 lakh crore in 2022-23, making up about 4.1 per cent of the GDP.

"A phenomenal increase in the government's capital expenditure is likely to facilitate the expenditures on infrastructure and create jobs. It also paves the way for post-pandemic longer-term restructuring of the India economy," Karun Rishi, president of Boston-based USA India Chamber of Commerce (USAIC) said.

However, it is a matter of concern that the budget lacks tangible measures to increase revenue generation, he noted.

Stating that the finance minister has incorporated innovative measures in the budget, Rishi said the new battery swapping' policy for electric vehicle sector can offer a practical alternative to increase the adoption of electric vehicles in India.

'One Nation, One Registration' will facilitate ease of living and doing business. Building up on the Technologies of the Future' announced during the 2018 budget, digital rupee to be issued by the Reserve Bank of India using blockchain technology will give a big boost to the economy, he added.

"The extension of Section 115BAB provision of 15 per cent for newly incorporated manufacturing companies is another excellent step to promote the much-needed investments in the manufacturing sector. The budget does give a blueprint of economy from India at 75 to India at 100'," the USAIC president said in a statement.

Noting that the pandemic has taught the world the importance of BioPharma Research and Development (R&D), Rishi said for over a decade, USAIC has been nudging India to create an ecosystem of academia, industry, venture capitalists and public institutions to foster innovation in BioPharma.

It is encouraging to see classification of genomics and pharmaceuticals as a sunrise sector. With this, India continues its thrust towards BioPharma R&D, he said.

« Back to LIVE

TOP STORIES

Not changing 2G judgment, non-auction allocation only for...: Sources

The government is not seeking to change the 2012 Supreme Court judgment that backed auction as the preferred mode of allocating telecom spectrum except for narrowly defined sectors such as satellite communication and defence where the...

It's Modi govt that wanted to bring inheritance tax: Cong

Amid the row over Congress leader Sam Pitroda's remarks, the party on Wednesday asserted that it has no plans whatsoever to introduce an inheritance tax and cited former Union minister Jayant Sinha's remarks to allege that it is the Modi...

'Can't control polls': SC to EVM critics as it reserves order

The Supreme Court said on Wednesday it cannot 'control the elections' or issue directions simply because doubts have been raised about the efficacy of Electronic Voting Machines (EVM), as it reserved its judgment on a clutch of petitions...

Modi's 'redistribution' charge against Cong gets Pitroda's booster

In his poll rallies, Modi framed Pitroda's comments in his wider onslaught against the Congress, asserting that they have exposed its hidden agenda and that the party has become so removed from the country's social and family values that...

IPL PIX: Pant shines as spirited Delhi Capitals edge Titans

Rishabh Pant's belligerent unbeaten half-century helped Delhi Capitals' to a narrow four-run win over Gujarat Titans.